{"id":"https://openalex.org/W7220983098","doi":"https://doi.org/10.7759/cureus.117629","title":"Outcomes of Patients With Chronic Lymphocytic Leukemia Treated With Bruton Tyrosine Kinase Inhibitors (BTKi): A Retrospective Study From a Tertiary Healthcare Center in North India","display_name":"Outcomes of Patients With Chronic Lymphocytic Leukemia Treated With Bruton Tyrosine Kinase Inhibitors (BTKi): A Retrospective Study From a Tertiary Healthcare Center in North India","publication_year":2026,"publication_date":"2026-10-08","ids":{"openalex":"https://openalex.org/W7220983098","doi":"https://doi.org/10.7759/cureus.117629","pmid":"https://pubmed.ncbi.nlm.nih.gov/42999795","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13744091"},"language":"en","primary_location":{"id":"doi:10.7759/cureus.117629","doi":"https://doi.org/10.7759/cureus.117629","is_oa":true,"landing_page_url":"https://doi.org/10.7759/cureus.117629","pdf_url":"https://www.cureus.com/articles/402620-outcomes-of-patients-with-chronic-lymphocytic-leukemia-treated-with-bruton-tyrosine-kinase-inhibitors-btki-a-retrospective-study-from-a-tertiary-healthcare-center-in-north-india.pdf","source":{"id":"https://openalex.org/S2738950867","display_name":"Cureus","issn_l":"2168-8184","issn":["2168-8184"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310316779","host_organization_name":"Cureus, Inc.","host_organization_lineage":["https://openalex.org/P4310316779"],"host_organization_lineage_names":["Cureus, Inc."],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.cureus.com/articles/402620-outcomes-of-patients-with-chronic-lymphocytic-leukemia-treated-with-bruton-tyrosine-kinase-inhibitors-btki-a-retrospective-study-from-a-tertiary-healthcare-center-in-north-india.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5020622747","display_name":"Alpika Shukla","orcid":"https://orcid.org/0000-0002-2687-0587","observed_orcids":["https://orcid.org/0000-0002-2687-0587"]},"institutions":[{"id":"https://openalex.org/I280994","display_name":"King George's Medical University","ror":"https://ror.org/00gvw6327","country_code":"IN","type":"education","lineage":["https://openalex.org/I280994"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Alpika Shukla","raw_affiliation_strings":["Hematology and Oncology/Clinical Hematology, King George's Medical University, Lucknow, IND"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology and Oncology/Clinical Hematology, King George's Medical University, Lucknow, IND","institution_ids":["https://openalex.org/I280994"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5157953993","display_name":"Amit Pandey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126423","display_name":"Dr. Ram Manohar Lohia Institute of Medical Sciences","ror":"https://ror.org/031xx1847","country_code":"IN","type":"healthcare","lineage":["https://openalex.org/I4210126423"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Amit Pandey","raw_affiliation_strings":["Medical Oncology, Dr. Ram Manohar Lohia Institute of Medical Sciences, Lucknow, IND"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Dr. Ram Manohar Lohia Institute of Medical Sciences, Lucknow, IND","institution_ids":["https://openalex.org/I4210126423"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059390372","display_name":"S K Verma","orcid":"https://orcid.org/0000-0003-1766-4850","observed_orcids":["https://orcid.org/0000-0003-1766-4850"]},"institutions":[{"id":"https://openalex.org/I280994","display_name":"King George's Medical University","ror":"https://ror.org/00gvw6327","country_code":"IN","type":"education","lineage":["https://openalex.org/I280994"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Shailendra P Verma","raw_affiliation_strings":["Hematology and Oncology/Clinical Hematology, King George's Medical University, Lucknow, IND"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology and Oncology/Clinical Hematology, King George's Medical University, Lucknow, IND","institution_ids":["https://openalex.org/I280994"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104026431","display_name":"Swasti Sinha","orcid":"https://orcid.org/0000-0002-2413-8894","observed_orcids":["https://orcid.org/0000-0002-2413-8894"]},"institutions":[{"id":"https://openalex.org/I280994","display_name":"King George's Medical University","ror":"https://ror.org/00gvw6327","country_code":"IN","type":"education","lineage":["https://openalex.org/I280994"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Swasti Sinha","raw_affiliation_strings":["Clinical Hematology, King George's Medical University, Lucknow, IND"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Hematology, King George's Medical University, Lucknow, IND","institution_ids":["https://openalex.org/I280994"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5157940434","display_name":"Anil Tripathi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anil Tripathi","raw_affiliation_strings":["Hematology and Oncology/Clinical Hematology, Hind Institute of Medical Sciences, Lucknow, IND"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology and Oncology/Clinical Hematology, Hind Institute of Medical Sciences, Lucknow, IND","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5157901870","display_name":"Neha Shukla","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I186246823","display_name":"University of Lucknow","ror":"https://ror.org/03bdeag60","country_code":"IN","type":"education","lineage":["https://openalex.org/I186246823"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Neha Shukla","raw_affiliation_strings":["Statistics, University of Lucknow, Lucknow, IND"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Statistics, University of Lucknow, Lucknow, IND","institution_ids":["https://openalex.org/I186246823"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000647363","display_name":"Gaurav Dutta","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I280994","display_name":"King George's Medical University","ror":"https://ror.org/00gvw6327","country_code":"IN","type":"education","lineage":["https://openalex.org/I280994"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Gaurav Dutta","raw_affiliation_strings":["Hematology and Oncology/Clinical Hematology, King George's Medical University, Lucknow, IND"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology and Oncology/Clinical Hematology, King George's Medical University, Lucknow, IND","institution_ids":["https://openalex.org/I280994"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5157977056","display_name":"P Raghuveer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I280994","display_name":"King George's Medical University","ror":"https://ror.org/00gvw6327","country_code":"IN","type":"education","lineage":["https://openalex.org/I280994"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"P Raghuveer","raw_affiliation_strings":["Hematology and Oncology/Clinical Hematology, King George's Medical University, Lucknow, IND"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology and Oncology/Clinical Hematology, King George's Medical University, Lucknow, IND","institution_ids":["https://openalex.org/I280994"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.73452246,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"18","issue":"10","first_page":"e117629","last_page":"e117629"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":1.0},{"id":"https://openalex.org/keywords/bruton-tyrosine-kinase-inhibitors","display_name":"BTK inhibitors","score":0.996999979019165},{"id":"https://openalex.org/keywords/acalabrutinib","display_name":"acalabrutinib","score":0.9959999918937683},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9110000133514404},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":1.0},{"id":"https://openalex.org/keywords/drug-toxicity","display_name":"drug toxicity","score":0.6790000200271606},{"id":"https://openalex.org/keywords/cardiotoxicity","display_name":"cardiotoxicity","score":0.6890000104904175},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.7129999995231628},{"id":"https://openalex.org/keywords/atrial-fibrillation","display_name":"atrial fibrillation","score":0.984000027179718},{"id":"https://openalex.org/keywords/gastrointestinal-side-effects","display_name":"gastrointestinal adverse effects","score":0.9129999876022339},{"id":"https://openalex.org/keywords/richter-transformation","display_name":"Richter transformation","score":0.9639999866485596},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.7599999904632568},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.5590000152587891},{"id":"https://openalex.org/keywords/13q-deletion","display_name":"13q deletion","score":0.8050000071525574},{"id":"https://openalex.org/keywords/indian-patients","display_name":"Indian patients","score":0.6729999780654907}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.972000002861023},{"id":"https://openalex.org/C3020131210","wikidata":"https://www.wikidata.org/wiki/Q1058785","display_name":"North india","level":2,"score":0.7390000224113464},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.690500020980835},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6621000170707703},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.6467999815940857},{"id":"https://openalex.org/C90059517","wikidata":"https://www.wikidata.org/wiki/Q423572","display_name":"Bruton's tyrosine kinase","level":4,"score":0.5131000280380249},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4749999940395355},{"id":"https://openalex.org/C2779463800","wikidata":"https://www.wikidata.org/wiki/Q5062222","display_name":"Center (category theory)","level":2,"score":0.45509999990463257},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.43939998745918274},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.4077000021934509},{"id":"https://openalex.org/C2991842025","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Tertiary care","level":2,"score":0.4032999873161316},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.3230000138282776},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.30140000581741333}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.7759/cureus.117629","doi":"https://doi.org/10.7759/cureus.117629","is_oa":true,"landing_page_url":"https://doi.org/10.7759/cureus.117629","pdf_url":"https://www.cureus.com/articles/402620-outcomes-of-patients-with-chronic-lymphocytic-leukemia-treated-with-bruton-tyrosine-kinase-inhibitors-btki-a-retrospective-study-from-a-tertiary-healthcare-center-in-north-india.pdf","source":{"id":"https://openalex.org/S2738950867","display_name":"Cureus","issn_l":"2168-8184","issn":["2168-8184"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310316779","host_organization_name":"Cureus, Inc.","host_organization_lineage":["https://openalex.org/P4310316779"],"host_organization_lineage_names":["Cureus, Inc."],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"journal-article"},{"id":"pmid:42999795","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42999795","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.7759/cureus.117629","doi":"https://doi.org/10.7759/cureus.117629","is_oa":true,"landing_page_url":"https://doi.org/10.7759/cureus.117629","pdf_url":"https://www.cureus.com/articles/402620-outcomes-of-patients-with-chronic-lymphocytic-leukemia-treated-with-bruton-tyrosine-kinase-inhibitors-btki-a-retrospective-study-from-a-tertiary-healthcare-center-in-north-india.pdf","source":{"id":"https://openalex.org/S2738950867","display_name":"Cureus","issn_l":"2168-8184","issn":["2168-8184"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310316779","host_organization_name":"Cureus, Inc.","host_organization_lineage":["https://openalex.org/P4310316779"],"host_organization_lineage_names":["Cureus, Inc."],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7220983098.pdf","grobid_xml":"https://content.openalex.org/works/W7220983098.grobid-xml"},"referenced_works_count":17,"referenced_works":["https://openalex.org/W2018466312","https://openalex.org/W2075875145","https://openalex.org/W2605172177","https://openalex.org/W2774167746","https://openalex.org/W2775394648","https://openalex.org/W2777218125","https://openalex.org/W2789508123","https://openalex.org/W2791299132","https://openalex.org/W2806627663","https://openalex.org/W2944976872","https://openalex.org/W3033667097","https://openalex.org/W3119940669","https://openalex.org/W3139157067","https://openalex.org/W4205825534","https://openalex.org/W4308963956","https://openalex.org/W4371781163","https://openalex.org/W4386813650"],"related_works":["https://openalex.org/W7161823624","https://openalex.org/W4413781584","https://openalex.org/W4405046816","https://openalex.org/W7160552922","https://openalex.org/W7164490451","https://openalex.org/W4416947041","https://openalex.org/W4379979631","https://openalex.org/W4405048671","https://openalex.org/W7204716218","https://openalex.org/W4310103280"],"abstract_inverted_index":{"BACKGROUND":[0],"AND":[1,84],"OBJECTIVES:":[2],"Bruton":[3],"tyrosine":[4],"kinase":[5],"inhibitors":[6],"(BTKi)":[7],"are":[8,63],"a":[9,38,117,208],"pivotal":[10],"advancement":[11],"in":[12,59,71,152,173,179,185,193,231],"treating":[13],"chronic":[14],"lymphocytic":[15],"leukemia":[16],"(CLL).":[17],"However,":[18],"their":[19],"adoption":[20],"faces":[21],"challenges":[22],"such":[23],"as":[24,149],"high":[25],"discontinuation":[26,237],"rates":[27],"caused":[28],"by":[29],"adverse":[30,189],"events":[31,170,190],"like":[32],"cardiac":[33],"and":[34,37,50,68,76,103,110,182,218,228],"hematologic":[35],"toxicities":[36],"significant":[39],"financial":[40],"burden.":[41],"Our":[42],"study":[43,89],"aims":[44],"to":[45,64,77,165,202],"evaluate":[46,65],"the":[47,79,143,159,239],"clinical":[48],"spectrum":[49],"outcomes":[51],"of":[52,120,211],"patients":[53,73,94,109,113,126,154],"with":[54,95,98,116,156],"CLL":[55,72,96,233],"receiving":[56],"BTKi":[57,75,80,99,146,224],"therapy":[58,151,225],"India.":[60],"The":[61],"objectives":[62],"progression-free":[66,214],"survival":[67,70,215,220],"overall":[69,219],"on":[74],"assess":[78],"toxicity":[81],"profile.":[82],"MATERIALS":[83],"METHODS:":[85],"This":[86],"retrospective,":[87],"single-center":[88],"analyzed":[90],"data":[91],"from":[92],"41":[93],"treated":[97],"between":[100],"January":[101],"2019":[102],"November":[104],"2024.":[105],"RESULTS:":[106],"Twenty-five":[107],"male":[108],"16":[111],"female":[112],"were":[114,171,191],"evaluated,":[115],"median":[118,209],"age":[119],"64":[121],"years":[122],"(range":[123],"42-90).":[124],"Twelve":[125],"(29.2%)":[127],"had":[128,135,199],"no":[129],"cytogenetic":[130],"abnormalities,":[131],"while":[132],"29":[133,153],"(70.7%)":[134],"at":[136],"least":[137],"one":[138],"abnormality;":[139],"13q":[140],"deletion":[141],"was":[142,147,216,221],"most":[144,160],"common.":[145],"used":[148,162],"first-line":[150],"(70.7%),":[155],"acalabrutinib":[157],"being":[158],"commonly":[161],"agent,":[163],"administered":[164],"17":[166],"(58.6%)":[167],"patients.":[168,196],"Cardiac":[169],"observed":[172],"8":[174],"(19.5%)":[175],"patients,":[176,234],"including":[177],"hypertension":[178],"four":[180],"(9.7%)":[181],"atrial":[183],"fibrillation":[184],"two":[186],"(4.9%).":[187],"Gastrointestinal":[188],"noted":[192],"7":[194],"(17%)":[195],"One":[197],"patient":[198],"Richter":[200],"transformation":[201],"diffuse":[203],"large":[204],"B-cell":[205],"lymphoma.":[206],"At":[207],"follow-up":[210],"24":[212],"months,":[213],"80%":[217],"95%.":[222],"CONCLUSIONS:":[223],"is":[226],"effective":[227],"well":[229],"tolerated":[230],"Indian":[232],"but":[235],"early":[236],"highlights":[238],"need":[240],"for":[241],"improved":[242],"adherence":[243],"strategies.":[244]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2026-10-09T00:00:00"}